Integrity BMS    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

Keynote Address
Harmonization of the European and the US Experience with the New Requirements
PFO Closure/Migraine - FDA View
PFO Closure/Migraine - Academic View
Report from the Standardization of Clinical Endpoints for Drug Eluting Stents Trials: Is it Time for a Change?







 

 

Long Working Hours & Stroke

The cardiovascular impact of working long hours has been the subject of much speculation. A meta-analysis of 25 studies has indicated that working long hours (≥55 per week) is associated with a higher risk of stroke than those working standard hours.

For more, click here

 

 

 

Clinical Outcomes in Peripartum Cardiomyopathy

Peripartum cardiomyopathy is associated with significant morbidity and mortality. Factors associated with clinical and ventricular recovery are sparse. Results from the IPAC study have indicated that although most women make a successful recovery, 13% have major events or severe cardiomyopathy. An initial LVEF<30%, LVEDD≥6.0 cm, black race, and presentation after 6 weeks postpartum were associated with a lower LV ejection fraction 1 year post partum.


For more, click here

 

 

 

 

Mechanism of SCD in MVP

The anatomical basis of ventricular instability in patients with mitral valve prolapse (MVP) is unknown. The cardiac pathology registry of 650 young adults with sudden cardiac death (SCD) has indicated that fibrosis of the papillary muscle and inferobasal left ventricular wall is the anatomical hallmark of ventricular arrhythmia.

For more, click here

 

 

 

Biomarkers in AAA

There are currently no robust biomarkers for screening/diagnosis of abdominal aortic aneurysm (AAA). Data from the Atherosclerosis Risk in Communities Study have identified white blood cell count, fibrinogen, D-Dimer, troponin T, N-terminal pro-brain natriuretic peptide, and high-sensitivity CRP as being strongly associated with AAA incidence. The more markers that fell into the highest quartile, the greater the risk of AAA was found to be.

For more, click here

 

<
||
>



















CRT2013
 
Selecting the Right FFR in an Unsteady State: Keep It Simple
- Morton Kern, MD
Transcatheter Structural Heart Interventions for the treatment of Chronic Heart Failure
- Dr Josep Rodes Cabau, MD
The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction
- Thomas Engstrøm, MD, DMSci, PhD
Relationship between hospital PTCA volume and in-hospital outcomes: Is it still true 9 years later?
- Christian Spaulding, M.D., FACC, FESC
The EGO-BioFreedom Study
- Stephen Lee, MD
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis
- George L. Zorn, III, MD
The Risk and Extent of Neurological Events Are Equivalent for High-Risk Patients Treated With Transcatheter or Surgical Aortic Valve Replacement
- Thomas G. Gleason, MD
Valve Thrombosis After TAVR: Frequency, Clinical Recognition, and Management
- Azeem Latib, MD



 Azeem Latib, MDSelecting the Right FFR in an Unsteady State: Keep It Simple
- Morton Kern, MD



 Azeem Latib, MDImpact of Pulmonary Hypertension Hemodynamic presentation on clinical outcomes in patients with severe sympotomatic Aortic Vavle Stenosis undergoing Transcatheter Aortic Vavle Implantation.
- CJ Sullivan, MD


 Azeem Latib, MDTranscatheter Heart Interveventions for the treatment of Chronic Heart Failure
- Dr Josep Rodes Cabau, MD


Philippe Pibarot, M.DTricuspid regurgitation with increased mortality with LF-LG AS
- Philippe Pibarot, M.D


Dr. Christian Spaulding, M.DRelationship between hospital PTCA volume and in-hospital outcomes- Is it still true 9 years later
- Christian Spaulding, M.D., FACC, FESC


Joanna Chikwe, MDA Prospective Randomized Evaluation of the TriGuard Embolic DEFLECTion Device During Transcatheter Aortic Valve Replacement
- Alexandra Lansky, MD


Joanna Chikwe, MDOne-Stage Off-Pump Transapical Mitral Valve Repair and Aortic Valve Replacement
- Andrea Colli, MD



 Azeem Latib, MD Early TAVR Thrombosis
- Azeem Latib, MD



 Click here to visit the WEBEX archives

Untitled Document
Physiological Growth, Remodeling Potential, and Preserved Function of a Novel Bioprosthetic Tricuspid Valve: Tubular Bioprosthesis Made of Small Intestinal Submucosa-Derived Extracellular Matrix.
F Zafar, et al.
JACC 2015; 66:877-888
Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From Wall Shear Stress Mapping.
D Guzzardi, et al.
JACC 2015; 66:892-900
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
D McNamara, et al.
JACC 2015; 66:905-914
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines–Heart Failure Registry.
H Golwala, et al.
JACC 2015; 66:917-926
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death.
C Basso, et al.
Circ 2015; 132:556-566
Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study.
A Folsom, et al.
Circ 2015; 132:578-585
Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women.
M Marklund, et al.
Circ 2015; 132:586-594
Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence.
A Leventhal, et al.
JAMA 2015;314:700-707
Long Working Hours and Risk of Coronary Heart Disease and Stroke: A Systematic Review and Meta-Analysis of Published and Unpublished Data for 603?838 Individuals.
Mika Kivimäki, et al.
The Lancet 2015 Online
Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction.
R Jabbari, et al.
AJC 2015; 116:678-685
Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.
A Matteau, et al.
AJC 2015; 2015:686-693
Sex Differences in Health Behavior Change After Premature Acute Coronary Syndrome.
S Yinko, et al.
AHJ 2015; 170:242-248



Poll Archives

Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD

Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD




8/27/2015
Gore Unveils Q50® PLUS Stent Graft Balloon Catheter

8/27/2015
Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

8/27/2015
TriVascular Announces First Patient Enrolled in the LUCY Study

8/27/2015
Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System

8/26/2015
Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device

8/20/2015
QualiMed's QBX 5-F Balloon-Expandable Stent System Launched in Europe

8/20/2015
FDA Clears Phase-2 Trial for Hemostemix Drug to Treat CLI

8/20/2015
Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab

8/17/2015
First Patient Enrolled in AngioDynamics’ RAPID Outcomes Database

8/17/2015
Penumbra to Distribute InspireMD’s CGuard EPS in Europe and International Markets

8/17/2015
First European Patients Enrolled in Study of Medtronic’s Endurant Evo AAA Stent Graft System

8/17/2015
Avinger Announces Early 510(k) Filing for Pantheris

8/7/2015
Lombard Acquires Low-Profile EVAR Device Developer Altura Medical

8/7/2015
NDC Acquires Interface Catheter Solutions; to Become Confluent Medical Technologies

8/7/2015
Vascular Solutions Announces Launch of 0.035-Inch Catheters for PolarCath System

8/7/2015
Gynesonics’ Investigational Sonata System Receives New AMA CPT Code for Uterine Fibroids Treatment

8/7/2015
Cook Medical Issues Global Recall of Beacon Tip Angiographic Catheter Products

8/7/2015
Merit Medical’s QuadraSphere Microspheres Receive Expanded Clearance for Hepatoma

8/7/2015
FDA Approves TriVascular’s Ovation iX Abdominal Stent Graft System

8/7/2015
SVS Elects Bruce A. Perler, MD, Ronald M. Fairman, MD, and R. Clement Darling III, MD, to Leadership

8/7/2015
Update to TASC II Guidelines Addresses Below-the-Knee PAD

8/7/2015
Medtronic Launches the Entrust Delivery System in the United States

7/22/2015
Blue Cross Blue Shield Association Study Shows Cost Variations for PCI

7/22/2015
Hospira Launches Generic Bivalirudin in the United States

7/22/2015
FAST Enrollment Begins for Boston Scientific’s Fully Resorbable Drug-Eluting Scaffold

7/22/2015
First Patient Enrolled in OrbusNeich’s China Recovery Study

7/22/2015
Micell Technologies Announces First Patient Enrolled in Registration of MiStent SES in China

7/10/2015
Vygon Group Acquires Perouse Medical

7/10/2015
M2S and Medstreaming to Collaborate on Automated Interface for VQI’s Pathways Registry

7/10/2015
FDA Clears CSI’s Next-Generation ViperWire With Flex Tip

7/8/2015
Cardiac Dimensions announces initial enrolments in REDUCE FMR clinical trial

7/8/2015
New study will compare OCT with IVUS for guided stent placement

7/8/2015
Daiichi Sankyo’s Edoxaban Approved in Europe
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2015, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb